◆英語タイトル:ObsEva SA (OBSV) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH495306FSA
◆発行会社(調査会社):
GlobalData
◆発行日:2020年12月
◆ページ数:49
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
ObsEva SA (OBSV) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
ObsEva SA (ObsEva) is a clinical-stage biopharmaceutical company that develops and commercializes drugs for women’s reproductive health and pregnancy. The company’s product portfolio comprises pipeline products for controlling preterm labor by reducing inflammation, decreasing uterine contractions and preventing cervical changes and membrane ruptures; for the treatment of pain associated with endometriosis and heavy menstrual bleeding associated with uterine fibroids in pre-menopausal women and to decrease contractions, improve uterine blood flow and enhance the receptivity of the endometrium to embryo implantation. ObsEva is headquartered in Geneva, Switzerland
ObsEva SA Key Recent Developments
Nov 09,2020: ObsEva appoints Brian O’Callaghan as Chief Executive Officer
Nov 05,2020: ObsEva announces third quarter 2020 financial results and business update
Aug 06,2020: ObsEva announces second quarter 2020 financial results and business update
May 05,2020: ObsEva announces first quarter 2020 financial results and business update
Apr 06,2020: ObsEva announces new interim Chief Financial Officer
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
ObsEva SA – Key Facts
ObsEva SA – Key Employees
ObsEva SA – Key Employee Biographies
ObsEva SA – Major Products and Services
ObsEva SA – History
ObsEva SA – Company Statement
ObsEva SA – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
ObsEva SA – Business Description
ObsEva SA – Corporate Strategy
ObsEva SA – SWOT Analysis
SWOT Analysis – Overview
ObsEva SA – Strengths
ObsEva SA – Weaknesses
ObsEva SA – Opportunities
ObsEva SA – Threats
ObsEva SA – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
ObsEva SA, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
ObsEva SA, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
ObsEva SA, Recent Deals Summary
Section 5 – Company’s Recent Developments
Nov 09, 2020: ObsEva appoints Brian O’Callaghan as Chief Executive Officer
Nov 05, 2020: ObsEva announces third quarter 2020 financial results and business update
Aug 06, 2020: ObsEva announces second quarter 2020 financial results and business update
May 05, 2020: ObsEva announces first quarter 2020 financial results and business update
Apr 06, 2020: ObsEva announces new interim Chief Financial Officer
Mar 23, 2020: ObsEva provides update related to COVID-19 pandemic
Mar 05, 2020: ObsEva announces year end 2019 financial results and business update
Nov 07, 2019: ObsEva announces third quarter 2019 financial results
Sep 11, 2019: ObsEva announces new composition of its executive committee
Aug 07, 2019: ObsEva reports second quarter 2019 financial results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
ObsEva SA, Key Facts
ObsEva SA, Key Employees
ObsEva SA, Key Employee Biographies
ObsEva SA, Major Products and Services
ObsEva SA, History
ObsEva SA, Subsidiaries
ObsEva SA, Key Competitors
ObsEva SA, Ratios based on current share price
ObsEva SA, Annual Ratios
ObsEva SA, Annual Ratios (Cont...1)
ObsEva SA, Interim Ratios
ObsEva SA, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
ObsEva SA, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
ObsEva SA, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios